Common joint supplement may accelerate Alzheimer’s disease progression
New research has found an association between taking glucosamine, a popular over-the-counter supplement used for joint pain, and…
New study shows how exercise hormone reduces multiple sclerosis symptoms
A new study offers clues as to why exercise can improve neurological symptoms in people with multiple sclerosis…
Tracking the aging process across tens of millions of individual cells
While much is mysterious about the aging process, change over time remains its cornerstone. The biological shifts that…
Neurodegeneration in Down syndrome may begin shortly after birth
Signs of neurodegeneration in individuals with Down syndrome may start as early as birth, a critical stage of…
Molecular map reveals how Down syndrome alters brain development
Scientists at UCLA have created one of the first cellular-resolution molecular maps detailing how Down syndrome alters human…
Glutathione Prevents Cellular Clogs – Neuroscience News
Summary: The endoplasmic reticulum (ER) is the cell’s busiest manufacturing hub, responsible for folding and exporting proteins. For…
How the immune system may influence Alzheimer’s, Parkinson’s, and related diseases
A sweeping review shows how the brain’s immune defenses can both fight and fuel neurodegeneration, revealing why timing,…
Aston University bioscientist receives £125,000 to investigate genetic reasons for neurodegeneration
Aston University bioscientist Dr John Reynolds has won a £125,000 Springboard grant from the Academy of Medical Sciences…
Study reveals lung-brain link between smoking and neurodegeneration
The correlation between smoking and neurodegeneration is well-documented, with one study from 2011 finding heavy smoking in midlife was associated…
Gut microbiome changes improve memory in early cognitive decline
From Mediterranean diets to probiotics, scientists reveal how reshaping the gut microbiome could help protect brain function, while…
AI Links Brain Rhythms to Physical “Wiring” Across Lifespan
Summary: For the first time, a multinational research team has mapped how the brain’s electrical activity evolves from…
Semaglutide Falls Short in Alzheimer’s Phase 3 Trials
Phase 3 trials show oral semaglutide failed to slow early Alzheimer’s progression, potentially limiting its expansion beyond metabolic…